These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 20009054)

  • 21. Experience with hepatitis A and B vaccines.
    Davis JP
    Am J Med; 2005 Oct; 118 Suppl 10A():7S-15S. PubMed ID: 16271535
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined hepatitis A and B vaccine: providing a bright future for preventing hepatitis.
    Hewlett AT
    Expert Opin Biol Ther; 2009 Sep; 9(9):1235-40. PubMed ID: 19601727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interference of antibody production to hepatitis B surface antigen in a combination hepatitis A/hepatitis B vaccine.
    Frey S; Dagan R; Ashur Y; Chen XQ; Ibarra J; Kollaritsch H; Mazur MH; Poland GA; Reisinger K; Walter E; Van Damme P; Braconier JH; Uhnoo I; Wahl M; Blatter MM; Clements D; Greenberg D; Jacobson RM; Norrby SR; Rowe M; Shouval D; Simmons SS; van Hattum J; Wennerholm S; Gress JO
    J Infect Dis; 1999 Dec; 180(6):2018-22. PubMed ID: 10558961
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lasting immune memory against hepatitis B following challenge 10-11 years after primary vaccination with either three doses of hexavalent DTPa-HBV-IPV/Hib or monovalent hepatitis B vaccine at 3, 5 and 11-12 months of age.
    Avdicova M; Crasta PD; Hardt K; Kovac M
    Vaccine; 2015 May; 33(23):2727-33. PubMed ID: 24962750
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Observation on two kinds of recombinant hepatitis B vaccines used in populations with different immunity].
    Zhang H; Ma JX; Gong XH; Liu LR; Wu K; Luo FJ; Zhao W; Zeng ZL; Bai YH; Sun LL; Xu W
    Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Aug; 27(8):690-3. PubMed ID: 17172109
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors].
    Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I
    Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ten year's experience with combined hepatitis A and B vaccine].
    Beran J
    Klin Mikrobiol Infekc Lek; 2008 Feb; 14(1):13-4, 16-23. PubMed ID: 18327736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [The immunogenicity of vaccines against diphtheria, tetanus, pertussis and polio administered orally on the vaccinal calendar at the age of 2, 4 and 6 months and their coadministration with a hepatitis B vaccine at 0, 2 and 6 months].
    Arístegui Fernández J; Muñiz Saitua J; Pérez Legorburu A; Imaz Pérez M; Arrate Zugazabeitia JP; Suárez Fernández MD; Goiri Zabala MD
    An Esp Pediatr; 1996 Jan; 44(1):25-8. PubMed ID: 8849056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunogenicity and safety of a Haemophilus influenzae B (Hib)-hepatitis B vaccine with a modified process hepatitis B component administered with concomitant pneumococcal conjugate vaccine to infants.
    Lee AW; Vesikari T; Gilbert CL; Klopfer SO; Schödel FP; Bhuyan PK
    Vaccine; 2011 Oct; 29(45):7942-8. PubMed ID: 21875633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficiency of the incorporation of the hepatitis A vaccine as a combined A+B vaccine to the hepatitis B vaccination programme of preadolescents in schools.
    Navas E; Salleras L; Gisbert R; Dominguez A; Bruguera M; Rodríguez G; Galí N; Prat A
    Vaccine; 2005 Mar; 23(17-18):2185-9. PubMed ID: 15755592
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New combined hepatitis A and B vaccine. New vaccine is an adjunct, not an alternative to preventive behaviours.
    Birthistle K; Benbow A
    BMJ; 1998 Apr; 316(7140):1317-8. PubMed ID: 9599053
    [No Abstract]   [Full Text] [Related]  

  • 32. Antibody persistence and immune memory 4 years post-vaccination with combined hepatitis A and B vaccine in adults aged over 40 years.
    Chlibek R; von Sonnenburg F; Van Damme P; Smetana J; Tichy P; Gunapalaiah B; Leyssen M; Jacquet JM
    J Travel Med; 2011; 18(2):145-8. PubMed ID: 21366801
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Interruption of perinatal transmission of HBV by Chinese recombinant hepatitis B vaccine].
    Yang C; Chen D; Li S
    Zhonghua Liu Xing Bing Xue Za Zhi; 1994 Dec; 15(6):343-5. PubMed ID: 7874702
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Challenge with a hepatitis B vaccine in two cohorts of 4-7-year-old children primed with hexavalent vaccines: an open-label, randomised trial in Italy.
    Zanetti A; Parlato A; Romanò L; Desole MG; Ferrera G; Giurdanella F; Zuliani M; Richard P; Thomas S; Fiquet A
    Vaccine; 2012 Aug; 30(39):5770-5. PubMed ID: 22789511
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatitis B Virus Revaccination With Standard Versus Pre-S Vaccine in Previously Immunized Patients With Celiac Disease.
    Heshin-Bekenstein M; Turner D; Shamir R; Bar-Meir M; Dagan R; Zevit N; Silbermintz A
    J Pediatr Gastroenterol Nutr; 2015 Oct; 61(4):400-3. PubMed ID: 25988560
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatitis vaccines.
    Katkov WN; Dienstag JL
    Gastroenterol Clin North Am; 1995 Mar; 24(1):147-59. PubMed ID: 7729858
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Vaccine choice and program participation rates when two hepatitis B vaccines are offered.
    Harris AA; Daly-Gawenda D; Hudson EK
    J Occup Med; 1991 Jul; 33(7):804-7. PubMed ID: 1832443
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A population-based, postlicensure evaluation of the safety of a combination diphtheria, tetanus, acellular pertussis, hepatitis B, and inactivated poliovirus vaccine in a large managed care organization.
    Zangwill KM; Eriksen E; Lee M; Lee J; Marcy SM; Friedland LR; Weston W; Howe B; Ward JI
    Pediatrics; 2008 Dec; 122(6):e1179-85. PubMed ID: 19047220
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Six-component vaccines: new preparations. Simpler hepatitis B vaccination of infants.
    Prescrire Int; 2004 Apr; 13(70):50-3. PubMed ID: 15148970
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Production and efficacy of a dendritic cell-based therapeutic vaccine for murine chronic hepatitis B virus carrierer.
    Akbar SM; Furukawa S; Hasebe A; Horiike N; Michitaka K; Onji M
    Int J Mol Med; 2004 Aug; 14(2):295-9. PubMed ID: 15254781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.